R&D Systems™ Recombinant Human FGF-8a Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
Supplier: R&D Systems™ 4745F8050
DescriptionThe Recombinant Human FGF-8a Protein is derived from E. coli. The Recombinant Human FGF-8a Protein has been validated for the following applications: Bioactivity.
|Lyophilized from a 0.2 μm filtered solution in MOPS, Na 2 SO 4 and EDTA.
|12 months from date of receipt, ≤ -20° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, ≤ -20° C under sterile conditions after reconstitution.
|FGF-8 a Isoform
|E. coli-derived human FGF-8 protein Gln23-Arg204,with an N-terminal Met
|95%, by SDS-PAGE under reducing conditions and visualized by silver stain.
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.Ok